The role of neurotrophins and insulin on tau pathology in Alzheimer's disease

被引:8
作者
Elliott, Evan [1 ]
Ginzburg, Irith [1 ]
机构
[1] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel
关键词
tau; Alzheimer's disease; neurotrophins; BDNF; insulin; phosphorylation;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Alterations in the structure and function of tau protein is the primary pathology of a variety of neurodegenerative diseases, including Alzheimer's disease (AD). In these diseases, hyperphosphorylated tau protein forms aggregates which are deposited in the somadendritic regions of the neurons in the central nervous system. This series of events is toxic to neurons, and plays a crucial role in disease development. However, the events leading to the deregulation of tau protein in AD are not clear. Recently, there has been much research into the possible roles of neurotrophic factors in AD. AD brain exhibits changes in levels of different neurotrophic factors, including brain-derived neurotrophic factor and nerve growth factor. These neurotrophic factors are known to be important for the proper functioning of neurons, and their deregulation may play an important role in AD disease progression. Of particular interest, these neurotrophic factors may play a role in the regulation and proper function of tau protein. In this review, the roles of neurotrophic factors in AD and in the regulation of tau protein are discussed.
引用
收藏
页码:635 / 642
页数:8
相关论文
共 49 条
[1]
ROLE OF ABNORMALLY PHOSPHORYLATED TAN IN THE BREAKDOWN OF MICROTUBULES IN ALZHEIMER-DISEASE [J].
ALONSO, AD ;
ZAIDI, T ;
GRUNDKEIQBAL, I ;
IQBAL, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5562-5566
[2]
Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation [J].
Babu, JR ;
Geetha, T ;
Wooten, MW .
JOURNAL OF NEUROCHEMISTRY, 2005, 94 (01) :192-203
[3]
Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in Italy [J].
Bagnoli, S ;
Nacmias, B ;
Tedde, A ;
Guarnieri, BM ;
Cellini, E ;
Petruzzi, C ;
Bartoli, A ;
Ortenzi, L ;
Sorbi, S .
ANNALS OF NEUROLOGY, 2004, 55 (03) :447-448
[4]
Bancher C, 1989, Prog Clin Biol Res, V317, P837
[5]
Glycogen synthase kinase 3: a drug target for CNS therapies [J].
Bhat, RV ;
Haeberlein, SLB ;
Avila, J .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (06) :1313-1317
[6]
PHOSPHORYLATION OF SER(262) STRONGLY REDUCES BINDING OF TAU-PROTEIN TO MICROTUBULES - DISTINCTION BETWEEN PHF-LIKE IMMUNOREACTIVITY AND MICROTUBULE-BINDING [J].
BIERNAT, J ;
GUSTKE, N ;
DREWES, G ;
MANDELKOW, EM ;
MANDELKOW, E .
NEURON, 1993, 11 (01) :153-163
[7]
Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease [J].
Bodner, SM ;
Berrettini, W ;
van Deerlin, V ;
Bennett, DA ;
Wilson, RS ;
Trojanowski, JQ ;
Arnold, SE .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 134B (01) :1-5
[8]
Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease [J].
Boissiere, F ;
Faucheux, B ;
Ruberg, M ;
Agid, Y ;
Hirsch, EC .
EXPERIMENTAL NEUROLOGY, 1997, 145 (01) :245-252
[9]
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice [J].
Capsoni, S ;
Ugolini, G ;
Comparini, A ;
Ruberti, F ;
Berardi, N ;
Cattaneo, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6826-6831
[10]
Tau is hyperphosphorylated in the insulin-like growth factor-I null brain [J].
Cheng, CM ;
Tseng, V ;
Wang, J ;
Wang, D ;
Matyakhina, L ;
Bondy, CA .
ENDOCRINOLOGY, 2005, 146 (12) :5086-5091